Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Performance of a New Generation IGRA in Immunocompromised Individuals

NCT02639936 is registered in ClinicalTrials.gov with Tuberculosis Network European Trialsgroup as lead sponsor.

NCT NCT02639936
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02639936 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Performance of a New Generation IGRA in Immunocompromised Individuals
Lead sponsor
Tuberculosis Network European Trialsgroup
Phase
Observational
Overall status
Completed
Start date
December 31, 2015
Completion date
December 31, 2023
Enrollment
2,663 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

active tuberculosis, monitoring, immunologic, tuberculosis in chronic renal failure, tuberculosis in hiv-infected individuals, tuberculosis in marrow transplant recipients, tuberculosis in rheumatoid arthritis, tuberculosis in solid organ transplant recipients